Strides Pharma Science Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 633.50 | 594.04 | 647.27 |
| Operating Expense | 546.94 | 520.19 | 526.92 |
| Net Profit | 15.31 | 2.40 | 53.66 |
| Net Profit Margin | 2.42 | 0.40 | 8.29 |
| Earning Per Share | 1.66 | 0.26 | 5.84 |
| EBIDTA | 84.42 | 73.75 | 118.41 |
| Effective Tax Rate | -3.49 | 1.44 | -2.35 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 633.50 |
| Operating Expense | 546.94 |
| Net Profit | 15.31 |
| Net Profit Margin | 2.42 |
| Earning Per Share | 1.66 |
| EBIDTA | 84.42 |
| Effective Tax Rate | -3.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,153.26 | 1,854.50 | 1,979.00 |
| Operating Expenses Annual | 1,897.98 | 1,756.02 | 1,902.37 |
| Operating Profit Annual | 322.22 | 167.54 | 200.12 |
| Interest Annual | 167.93 | 138.68 | 74.24 |
| Depreciation | 77.00 | 81.71 | 86.25 |
| Net Profit Annual | 65.49 | 4.68 | 180.19 |
| Tax Annual | 4.13 | -69.44 | -158.68 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,153.26 |
| Operating Expenses Annual | 1,897.98 |
| Operating Profit Annual | 322.22 |
| Interest Annual | 167.93 |
| Depreciation | 77.00 |
| Net Profit Annual | 65.49 |
| Tax Annual | 4.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 82.11 | 12.12 | 25.30 |
| Cash Flow from Operations | -35.76 | 241.74 | -282.69 |
| Cash Flow from Investing | -61.27 | -182.58 | 18.78 |
| Cash Flow from Financing | 107.62 | 10.82 | 250.73 |
| Cash Flow at the End | 92.71 | 82.11 | 12.12 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 82.11 |
| Cash Flow from Operations | -35.76 |
| Cash Flow from Investing | -61.27 |
| Cash Flow from Financing | 107.62 |
| Cash Flow at the End | 92.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 14.96 | 9.91 | 9.57 |
| PBIT Margin (%) | 11.03 | 4.87 | 4.29 |
| PBT Margin (%) | 10.96 | 4.83 | 4.23 |
| Net PROFIT Margin (%) | 3.04 | 0.25 | 9.11 |
| Return On Networth / Equity (%) | 1.87 | 0.61 | 5.29 |
| Return On Networth /Employed (%) | 4.68 | 1.87 | 1.87 |
| Return On Assets (%) | 1.28 | 0.10 | 3.92 |
| Total Debt / Equity (X) | 0.44 | 0.39 | 0.33 |
| Asset Turnover Ratio (%) | 0.42 | 0.39 | 0.43 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 14.96 |
| PBIT Margin (%) | 11.03 |
| PBT Margin (%) | 10.96 |
| Net PROFIT Margin (%) | 3.04 |
| Return On Networth / Equity (%) | 1.87 |
| Return On Networth /Employed (%) | 4.68 |
| Return On Assets (%) | 1.28 |
| Total Debt / Equity (X) | 0.44 |
| Asset Turnover Ratio (%) | 0.42 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 580.88 | 623.89 | 629.36 |
| Total Current Assets Annual | 2,415.86 | 2,126.40 | 1,975.25 |
| Non Current Assets Annual | 3,421.93 | 3,493.34 | 3,458.61 |
| Total Shareholders Funds Annual | 3,561.12 | 3,455.05 | 3,406.68 |
| Total Assets Annual | 5,837.78 | 5,619.74 | 5,433.86 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 580.88 |
| Total Current Assets Annual | 2,415.86 |
| Non Current Assets Annual | 3,421.93 |
| Total Shareholders Funds Annual | 3,561.12 |
| Total Assets Annual | 5,837.78 |
EPS (INR)
Expected
10.14
Reported
10.14
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
